Zacks Investment Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-849
Closed -$330K – 780
2025
Q2
$330K Buy
849
+182
+27% +$73.2K ﹤0.01% 541
2025
Q1
$290K Sell
667
-25
-4% -$10K ﹤0.01% 555
2024
Q4
$255K Sell
692
-291
-30% -$122K ﹤0.01% 586
2024
Q3
$511K Buy
+983
New +$525K ﹤0.01% 492
2024
Q2
– Sell
-903
Closed -$468K – 656
2024
Q1
$468K Sell
903
-39
-4% -$19.4K 0.01% 479
2023
Q4
$444K Buy
942
+430
+84% +$199K 0.01% 478
2023
Q3
$223K Sell
512
-18,525
-97% -$8.4M ﹤0.01% 558
2023
Q2
$8.46M Buy
+19,037
New +$8.78M 0.11% 152
2018
Q2
– Sell
-1,080
Closed -$237K – 563
2018
Q1
$237K Buy
+1,080
New +$254K 0.01% 487
2017
Q3
– Sell
-2,259
Closed -$425K – 601
2017
Q2
$425K Buy
+2,259
New +$406K 0.01% 470
2016
Q3
– Sell
-11,776
Closed -$1.55M – 671
2016
Q2
$1.55M Buy
11,776
+8,123
+222% +$1.11M 0.05% 252
2016
Q1
$508K Sell
3,653
-1,721
-32% -$230K 0.02% 445
2015
Q4
$749K Sell
5,374
-5,390
-50% -$743K 0.02% 352
2015
Q3
$1.51M Buy
+10,764
New +$1.62M 0.05% 228

Other funds holding ELV

Zacks Investment Management's ELV Position: Q3 2025 in Review

Zacks Investment Management sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 849 shares — an estimated $330K sold.

Zacks Investment Management first reported a position in ELV in Q3 2015 and held it in 14 quarters. The position peaked at $8.46M in Q2 2023. 1,512 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • Zacks Investment Management reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • Zacks Investment Management sold 849 Elevance Health shares in Q3 2025, an estimated $330K.
  • Zacks Investment Management first reported a position in Elevance Health in Q3 2015 and held it in 14 quarters.
  • Zacks Investment Management's Elevance Health position peaked at $8.46M in Q2 2023.
  • 1,512 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Zacks Investment Management's 13F filing for Q3 2025, filed 14 Nov 2025.